The clinical course of multiple sclerosis patients in Hong Kong

被引:26
|
作者
Lau, Kwok-Kwong [1 ]
Wong, Winnie Wing-Yin [2 ]
Sheng, Bun [1 ]
Yu, Ignatius Tak-Sun [3 ]
Fung, Bun-Hey [4 ]
Li, Ho-Lun [1 ]
Ma, Ka-Fai Johnny [5 ]
Wong, Lawrence Ka-Sing [6 ]
Li, Patrick Chung-Ki [2 ]
机构
[1] Princess Margaret Hosp, Dept Med & Geriatr, Kwai Chung, Hong Kong, Peoples R China
[2] Queen Elizabeth Hosp, Dept Med & Geriatr, Kowloon, Hong Kong, Peoples R China
[3] Chinese Univ Hong Kong, Dept Community & Family Med, Shatin, Hong Kong, Peoples R China
[4] United Christian Hosp, Dept Med & Geriatr, Kwun Tong, Hong Kong, Peoples R China
[5] Princess Margaret Hosp, Dept Radiol, Kwai Chung, Hong Kong, Peoples R China
[6] Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
关键词
multiple sclerosis; epidemiology; disease progression; Extended Disability Status Scale;
D O I
10.1016/j.jns.2007.11.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Multiple sclerosis (MS) has a low prevalence in Hong Kong. Objective: To reassess MS prevalence in Hong Kong and to examine associated risk factors for relapsing-remitting type MS patients to reach Kurtzke's Extended Disability Status Scale (EDSS) of 6.0, i.e. when walking aid was needed. Design: Retrospective observational study on MS patients over 11 years. Setting: Three tertiary hospitals in Hong Kong. Results: A hundred and six patients were recruited. Female to male ratio was 3.2:1 and the prevalence was 4.8 per 100,000.95 were relapsing-remitting (RR) type. The mean disease duration was 12.7 years (range: 1-45 years) and the duration of follow up was 11.0+/-0.8 (mean+/-SE) years. The initial mean EDSS was 1.59 and the latest mean EDSS was 4.26. 38 (40%) RR type MS patients progressed to EDSS 6.0 after a mean duration of 6.0 years. With Cox regression analysis, patients with older age (>35y) of onset (HR 2.57; 95% CI:1.29-5.11), higher EDSS of 2.0 or more upon presentation (HR 2.19; 95%CI: 1.12-4.26) were associated with progression to EDSS of 6.0, while there was a tendency towards slower disease progression for patients initially presenting with optic symptoms (HR 0.52; 95%CI: 0.23-1.16). The number of relapses and use of interferon could not be shown to have significant effect on disease progression. Conclusions: The local period prevalence ratio of MS was 4.8 per 100,000. Older age of onset and higher EDSS upon initial presentation were independent predictors for progression to EDSS of 6.0. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:78 / 82
页数:5
相关论文
共 50 条
  • [21] Discordance of reported multiple sclerosis clinical course amongst patients and providers
    Aboseif, Albert
    Amin, Moein
    Macaron, Gabrielle
    Ontaneda, Daniel
    JOURNAL OF NEUROIMMUNOLOGY, 2024, 395
  • [22] Clinical course of multiple sclerosis in Japanese patients treated with glatiramer acetate
    Okamoto, T.
    Lin, Y.
    Araki, M.
    Sato, W.
    Kawazoe, T.
    Wakasugi, N.
    Takewaki, D.
    Takahashi, Y.
    Yamamura, T.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 793 - 794
  • [23] A postgraduate EMC course in Hong Kong
    Leung, SW
    Fung, LC
    2003 IEEE INTERNATIONAL SYMPOSIUM ON ELECTROMAGNETIC COMPATIBILITY (EMC), VOLS 1 AND 2, SYMPOSIUM RECORD, 2003, : 1156 - 1158
  • [24] The evaluation of the clinical course of patients with progressive multiple sclerosis treated with Novantrone
    Lotfi, J
    Meftahpoor, M
    Soltanzadeh, A
    Shahrasbi, A
    JOURNAL OF NEUROLOGY, 2004, 251 : 64 - 64
  • [25] Clinical course in multiple sclerosis patients presenting with a history of progressive disease
    Pandey, K. S.
    Krieger, S. C.
    Farrell, C.
    Hannigan, C.
    DeAngelis, T.
    Miller, A. E.
    Lublin, F. D.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (01) : 67 - 71
  • [26] CLINICAL COURSE OF MULTIPLE SCLEROSIS IN PATIENTS TREATED WITH IMMUNOSUPPRESSIVE DRUGS FOR CANCER
    Santos-Garcia, D.
    Prieto, J. M.
    Lema, M.
    REVISTA DE NEUROLOGIA, 2009, 48 (02) : 71 - 74
  • [27] Evaluation of clinical course and prognosis in 100 Iranian multiple sclerosis patients
    Ashtari, E
    Shaygannejad, V
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S156 - S156
  • [28] Clinical indexes affecting the course and severity of the disease in multiple sclerosis patients
    Manova, M. G.
    Kostadinova, I. I.
    Trenova, A.
    Zahariev, Z. I.
    Vasileva, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 134 - 135
  • [29] Familial multiple sclerosis: clinical features and course
    Ekmekci, O.
    Yuceyar, A. N.
    EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 537 - 537
  • [30] MULTIPLE SCLEROSIS WITH PSEUDOTUMOROUS COURSE . ITS CLINICAL COURSE AND NEUROPATHOLOGY
    HERRMANN, E
    JACOB, H
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1968, 7 (01) : 1 - &